↓ Skip to main content

Exogenous surfactant therapy in 2013: what is next? who, when and how should we treat newborn infants in the future?

Overview of attention for article published in BMC Pediatrics, October 2013
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Exogenous surfactant therapy in 2013: what is next? who, when and how should we treat newborn infants in the future?
Published in
BMC Pediatrics, October 2013
DOI 10.1186/1471-2431-13-165
Pubmed ID
Authors

Emmanuel Lopez, Géraldine Gascoin, Cyril Flamant, Mona Merhi, Pierre Tourneux, Olivier Baud, for the French Young Neonatologist Club

Abstract

Surfactant therapy is one of the few treatments that have dramatically changed clinical practice in neonatology. In addition to respiratory distress syndrome (RDS), surfactant deficiency is observed in many other clinical situations in term and preterm infants, raising several questions regarding the use of surfactant therapy.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
Unknown 120 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 16%
Other 16 13%
Student > Postgraduate 16 13%
Researcher 15 12%
Professor > Associate Professor 10 8%
Other 27 22%
Unknown 19 16%
Readers by discipline Count As %
Medicine and Dentistry 71 58%
Agricultural and Biological Sciences 8 7%
Nursing and Health Professions 6 5%
Business, Management and Accounting 3 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 9 7%
Unknown 23 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2013.
All research outputs
#17,703,558
of 22,731,677 outputs
Outputs from BMC Pediatrics
#2,247
of 2,987 outputs
Outputs of similar age
#149,966
of 209,641 outputs
Outputs of similar age from BMC Pediatrics
#37
of 44 outputs
Altmetric has tracked 22,731,677 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,987 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,641 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.